F/m Investments LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1834499 WASHINGTON, DC

Position in REGN

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$10,464,871

-$2,966,702 QoQ

Shares Held

16,783

-3.5% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.79%

of 13F equity value

Holder Rank

#287

of 1,322 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

F/m Investments LLC holds $94,614,016 across 23 Biotechnology names. REGN ranks #2 (11.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	187,574	$10,656,078
2	REGN	Regeneron Pharmaceuticals, Inc. This page	16,783	$10,464,871
3	COGT	Cogent Biosciences, Inc.	228,688	$8,850,225
4	SYRE	Spyre Therapeutics, Inc.	92,618	$8,222,626
5	CORT	Corcept Therapeutics Inc	88,042	$7,655,251
6	MIRM	Mirum Pharmaceuticals, Inc.	51,483	$6,027,114
7	CYTK	Cytokinetics Inc	60,891	$5,187,304
8	MANE	Veradermics, Inc	35,967	$4,421,782

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,464,871	16,783	-3.5%	Shares	Sole	2026-08-05
2026-03-31	$13,431,573	17,384	-23.8%	Shares	Sole	2026-05-11
2025-12-31	$17,608,670	22,813	+248.7%	Shares	Sole	2026-02-03
2025-09-30	$3,678,932	6,543	-2.2%	Shares	Sole	2025-11-13
2025-06-30	$3,511,200	6,688	+1.3%	Shares	Sole	2025-08-13
2025-03-31	$4,185,283	6,599	-5.8%	Shares	Sole	2025-05-14
2024-12-31	$4,988,446	7,003	+8.5%	Shares	Sole	2025-02-13
2024-09-30	$6,783,651	6,453	-3.8%	Shares	Sole	2024-10-29
2024-06-30	$7,050,309	6,708	+47.9%	Shares	Sole	2024-07-29
2022-06-30	$2,681,956	4,537	-0.3%	Shares	Sole	2022-08-04
2021-09-30	$2,752,963	4,549	+0.3%	Shares	Sole	2021-11-01
2021-06-30	$2,534,095	4,537	—	Shares	Sole	2021-08-10
No filing history on record for this holder in this stock.